Hall Steven Edward
Related Filers (9)
- Lilly Ventures Fund I LLC (6)
- Torres S. Edward (6)
- LV Management Group, LLC (6)
- Cerulean Pharma Inc. (4)
- Kymera Therapeutics, Inc. (4)
- Forma Therapeutics Holdings, Inc. (3)
- Protagonist Therapeutics, Inc (2)
- AILERON THERAPEUTICS INC (2)
- Surface Oncology, Inc. (2)
- Show More ...
Ownership (17)
4
Thursday, 6/17/2021
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/25/2020
Forma Therapeutics Holdings, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/25/2020
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/21/2020
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/20/2020
Kymera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/22/2020
Forma Therapeutics Holdings, Inc.,: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
Forma Therapeutics Holdings, Inc.,: Initial statement of beneficial ownership of securities
4
Monday, 4/23/2018
Surface Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/18/2018
Surface Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 7/7/2017
AILERON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/28/2017
AILERON THERAPEUTICS INC: Initial statement of beneficial ownership of securities
4
Tuesday, 8/16/2016
Protagonist Therapeutics, Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/10/2016
Protagonist Therapeutics, Inc: Initial statement of beneficial ownership of securities
4
Friday, 6/24/2016
Cerulean Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/30/2015
Cerulean Pharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/15/2014
Cerulean Pharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/10/2014
Cerulean Pharma Inc.: Initial statement of beneficial ownership of securities